about
Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutantsCounteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu geneCovert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytesInnate sensing of HIV-infected cells.Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.HIV drug resistance and viral fitness.Hyperthermia stimulates HIV-1 replicationBaseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitorsImpact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell CultureHIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesRole of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1.Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transferRole of Gag in HIV Resistance to Protease InhibitorsKinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes.HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells.Automated genome-wide visual profiling of cellular proteins involved in HIV infection.The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA.Parameters driving the selection of nelfinavir-resistant human immunodeficiency virus type 1 variants.Number of infection events per cell during HIV-1 cell-free infection.Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues.Cell-to-cell infection by HIV contributes over half of virus infection.Perinatal infection by human immunodeficiency virus type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome.Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism.Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model.Impact of the HIV integrase genetic context on the phenotypic expression and in vivo emergence of raltegravir resistance mutations.Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection.Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations.Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues.
P50
Q27648939-3F1A61DE-6426-44DD-9084-884A30673994Q28730542-C9F57D3F-FF01-49BD-A283-C820E9A96482Q33755099-8DBCD814-C3EA-428D-BA61-56AA570D238BQ33838296-1FC51DA1-FD2E-4ED1-B865-12DF1BE344A0Q33843040-1F0A15DB-8B8B-41E3-B412-D9C07D89EBB0Q34050677-2A53DCE9-08CF-4BAC-9A39-929B90E144D2Q34341364-6143B865-D68C-4AA1-A2F1-2C9F8061D2B2Q34465544-80F8C3A5-BBCF-4FED-B4E3-B7C326FE1EC4Q35634348-83147FFD-924D-45C0-A0B4-9E45879500FBQ35791235-ADC92A41-3850-4151-A37D-02E52E47F20EQ35826780-03BE15C6-242B-4136-8E19-64C24BBA9178Q35914015-BFE3F03B-1E32-4B4B-A1AA-048D5889DE01Q36502557-F7BE59FD-D837-4D9E-BF8D-613E279728CBQ37093847-EAAA186B-55CB-471E-BCB0-E688FFE14D96Q37356024-2DF49DD0-B091-49A3-AC6E-D5A2DF8B1B4EQ37365399-EC991F6F-55B2-4BB3-8F6D-D200C22D87C0Q38615581-37900927-CCB7-46D3-99C3-14085AA6795DQ38825125-FA59E908-101B-445F-94A2-BED6388AFB02Q38964582-BD71A0CA-255C-4EFC-AF23-EE89919C69A2Q39025979-F2519B85-6156-45C3-B45F-835B1B327E4FQ39170271-739E5689-070C-44FB-9A65-A4659DE5EDE1Q39490430-85E0C3F8-C6A1-47CC-AB53-4C064217061DQ39592447-DFD0F7CB-31F8-4A9F-A699-8128C25552A4Q39996438-BFC738AB-D07F-4AC2-BE1E-66012EBE1BB8Q40106956-D59D1DB2-51B2-4010-AF4A-2CE396C5620FQ40448041-622AAEDD-FF55-4110-BEB0-ED22BB1A11F6Q40721745-9165F55A-8F32-4326-BEB2-554AD21AF720Q40964134-9C94F90E-B2EC-4CE1-BAF4-348F0D7795B0Q41654393-46D25C30-DCCF-424F-94D0-0E029CFDE9DEQ41666848-7B0CA260-6986-418E-AB43-05E5B548834AQ41723150-7D57D0AD-F0B7-44AB-B9A6-EC902C813614Q41908173-C0443191-4EF6-4DF3-A903-A3F7BE016D73Q42051978-CF9007A0-9DC2-4DF6-933D-111F7A7EE184Q42183134-296668AF-9401-415A-AAB3-37157609B61DQ43680943-54BE8CF0-B494-49D9-8724-8079ADC478DDQ43856545-9EA37EE4-9335-4755-8B25-A5BD03E1F881Q44435641-BC4769B9-7AA0-4F45-84D1-F54872B66612Q45786995-F00873BA-75C7-4FEC-A83F-5A222FC5C803Q46077795-9E3A6182-DE57-4A7B-AA5E-4346D9C6BC9DQ46118195-BB2518C0-D0AD-4713-BC20-5034068BE2FA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabrizio Mammano
@ast
Fabrizio Mammano
@en
Fabrizio Mammano
@es
Fabrizio Mammano
@nl
Fabrizio Mammano
@sl
type
label
Fabrizio Mammano
@ast
Fabrizio Mammano
@en
Fabrizio Mammano
@es
Fabrizio Mammano
@nl
Fabrizio Mammano
@sl
prefLabel
Fabrizio Mammano
@ast
Fabrizio Mammano
@en
Fabrizio Mammano
@es
Fabrizio Mammano
@nl
Fabrizio Mammano
@sl
P106
P1153
7006987415
P21
P31
P496
0000-0002-9193-7696